ClinConnect ClinConnect Logo
Search / Trial NCT01344213

Pregabalin, Celecoxib, Total Knee Arthroplasty and Intrathecal Morphine

Launched by CHULALONGKORN UNIVERSITY · Apr 27, 2011

Trial Information

Current as of May 25, 2025

Completed

Keywords

Pregabalin Celecoxib Intrathecal Morphine Total Knee Arthroplasty

ClinConnect Summary

A single-dose spinal anesthesia combining with morphine for total knee arthroplasty (TKA) is a simple, economical anesthetic technique commonly used in our hospital. Still some patients could not get effective postoperative pain control. Pregabalin, an anticonvulsant, has been shown to reduce acute pain after molar extraction, laparoscopic cholecystectomy, and reduce postoperative morphine requirement after total hip arthroplasty, and celecoxib, a selective cyclo-oxygenase (COX) - 2 inhibitor, with perioperative prescription is successfully reduces pain score and opioid consumption after TK...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients between 50-75 years of age
  • Patients with an American Society of Anesthesiologists physical status of I to III
  • Patients scheduled for primary TKA with a diagnosis of osteoarthritis under spinal anesthesia
  • Exclusion Criteria:.
  • Patients had a known allergy to any of the medications being used
  • a history of drug or alcohol abuse
  • a history of taking chronic pain medications (ie, show-release preparations of opioids, given that morphine consumption was the primary outcome)
  • a history of taking pregabalin or gabapentin / non-steroidal anti-inflammatory drugs / COX-2 inhibitors
  • a psychiatric disorder
  • a history of impaired renal function (Cr \> 1.5 mg/dl), peptic ulcer, asthma, thrombotic cerebrocardiovascular diseases, uncontrolled hypertension
  • a history of contraindication for spinal anesthesia
  • a history of bleeding tendency
  • pregnancy
  • unable or unwilling to use patient - controlled analgesic (PCA)

About Chulalongkorn University

Chulalongkorn University, one of Thailand's premier academic institutions, is dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise in various medical fields to conduct rigorous scientific investigations. Chulalongkorn University aims to contribute to global health advancements by fostering a culture of excellence in research, education, and community service, ultimately improving patient care and public health standards.

Locations

Bangkok, , Thailand

Patients applied

0 patients applied

Trial Officials

Supranee Niruthisard, BSc, MD

Principal Investigator

King Chulalongkorn Memorial Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials